tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

USANA Health Reports Q3 2025 Sales Increase

Story Highlights
  • USANA Health Sciences saw a 7% sales increase but reported a $6.5 million net loss.
  • The company is optimistic about growth, driven by new products and a revamped compensation plan.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
USANA Health Reports Q3 2025 Sales Increase

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

USANA Health ( (USNA) ) has issued an announcement.

USANA Health Sciences reported a 7% increase in net sales for the third quarter of 2025 compared to the same period in 2024, reaching $214 million. However, the company experienced a net loss of $6.5 million, attributed to investments in a new Brand Partner compensation plan and an increased effective tax rate. Despite these challenges, USANA remains optimistic about its long-term growth, supported by a successful Global Convention, new product launches, and a strategic focus on enhancing its Brand Partner network. The company also reported significant progress in its direct-to-consumer business, Hiya, which achieved 26% year-to-date sales growth and is expected to continue its upward trajectory.

The most recent analyst rating on (USNA) stock is a Hold with a $32.00 price target. To see the full list of analyst forecasts on USANA Health stock, see the USNA Stock Forecast page.

Spark’s Take on USNA Stock

According to Spark, TipRanks’ AI Analyst, USNA is a Neutral.

USANA Health’s overall stock score reflects a stable financial position with strong gross margins and a solid balance sheet. The positive sentiment from the earnings call, highlighting strategic growth initiatives and debt reduction, significantly boosts the score. However, technical indicators suggest weak momentum, and the company faces challenges with declining revenues and net profitability. The valuation is fair, but the lack of a dividend yield limits appeal for income investors.

To see Spark’s full report on USNA stock, click here.

More about USANA Health

USANA Health Sciences, Inc. operates in the health and wellness industry, primarily focusing on nutritional products and dietary supplements. The company engages in direct selling and has a significant market presence in various global regions, including Asia Pacific and the Americas.

Average Trading Volume: 153,388

Technical Sentiment Signal: Sell

Current Market Cap: $377.9M

For an in-depth examination of USNA stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1